Biotechnology company BPC Instruments reports both lower revenue and operating profit in the second quarter compared with the same period a year earlier. Revenue fell 11.2 percent to SEK 15.0 million (16.9).Operating profit was SEK 1.6 million (2.4), with an operating margin of 10.7 percent (14.2). Net profit was SEK 1.3 million (2.0), and earnings per share were SEK 0.12 (0.18).Cash flow from operating activities amounted to negative SEK 4.1 million (negative 0.2). Cash and cash equivalents amounted to SEK 9.9 million (14.6)."The improvement from the first quarter is positive, although overall performance during the first half remains below our expectations. Customer decision-making continues to be cautious in parts of Europe and North America, while interest in our solutions for both biogas and biodegradability remains," comments CEO Jing LiuBPC Instruments, SEK millionQ2-2026Q2-2025ChangeNet sales15.016.9-11.2%Operating profit1.62.4-33.3%Operating margin10.7%14.2%Net profit1.32.0-35.0%Earnings per share, SEK0.120.18-33.3%Cash flow from operating activities-4.1-0.2Cash and cash equivalents9.914.6-32.2%